Blood Pressure Lowering Effect of Fermented Milk Products

Yıl 2018, , 67 - 77, 23.04.2018

Mohamed H. Abd El-salam Safinaz El-shibiny

https://doi.org/10.24323/akademik-gida.417892

Öz

Hypertension (HTN) is a major risk factor for the development of cardiovascular
diseases. Therefore, there is a need to lower blood pressure (BP) to reduce the
risk of these degenerative diseases. Fermented milks contain several potential
factors that can lower BP including calcium and microbial metabolites
particularly the angiotension-converting enzyme (ACE) inhibitory peptides and
γ-aminobutyric acid.  Animal studies
clearly demonstrated the BP lowering effect of fermented milk while results
from clinical trials were controversial due to a large number of variables that
should be considered in clinical trials. An overview on the antihypertensive effect
of fermented milk products is presented and discussed in this review.

Anahtar Kelimeler

Fermented milks, Hypertension, Calcium, ACE-inhibitory peptides, γ-Aminobutyric acid

Fermente Süt Ürünlerinin Kan Basıncını Düşürücü Etkisi

Öz

Hipertansiyon (HTN), kardiyovasküler
hastalıkların oluşumu için önemli bir risk faktörüdür. Bu nedenle, söz konusu
dejeneratif hastalıkların riskini azaltmak için kan basıncını düşürme ihtiyacı
vardır. Fermente edilmiş sütler, kalsiyum ve mikrobiyal metabolitler, özellikle
de anjiyotensin-dönüştüren enzim (ACE) inhibitörü peptitler ve γ-aminobütirik
asit dahil olmak üzere, kan basıncını azaltabilen birkaç potansiyel faktör
içerir. Hayvan çalışmaları, fermente edilmiş sütün kan basıncını azaltma
etkisini açıkça gösterirken, klinik çalışmalarda elde edilen sonuçlar, klinik
çalışmalarda dikkate alınması gereken çok sayıda değişkenden dolayı
tartışmalıdır. Bu makalede fermente süt ürünlerinin antihipertansif etkisine
genel bir bakış sunulmakta ve tartışılmaktadır.

Anahtar Kelimeler

Fermente sütler, Hipertansiyon, Kalsiyum, ACE-inhibitörü peptitler, γ-aminobütirik asit

Kaynakça

• [1] Alton, I., 2005. Hypertension. In: Guidelines for Adolescent Nutrition Services. Stang J, Story M (eds) pp 125, http://www.epi.umn.edu/let/pubs/adol_book.shtm.
• [2] Hasan, D.M., Emeash, A.H., Mustafa, S.B., Abdelazim, G.E., El-din, A.A., 2014. Hypertension in Egypt: a systematic review. Current Hypertension Reviews 10: 134-41.
• [3] Lawes, C.M., Vander Hoorn, S., Rodgers, A., 2008. International Society of Hypertension. Global burden of blood-pressure-related disease. Lancet 371: 1513–1518.
• [4] Appel, L.J., Moore, T.J., Obarzanek, E., 1997. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. New England Journal of Medicine 336: 1117–1124.
• [5] Kris-Etherton, P.M., Grieger, J.A., Hilpert, K.F., West, S.G., 2009. Milk products, dietary patterns and blood pressure management. Journal of the American College of Nutrition 28: 103S–119S.
• [6] Wang, L., Manson, J.A.E., Buring, J.E., Lee, I-M., Sesso, H.D., 2008. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51 1-7.
• [7] Jauhiainen, T., Pilvi, T., Cheng, Z.J., Kautiainen, H., Müller, D.N., Vapaatalo, H. Korpela, R., Mervaala, E., 2010. Milk products containing bioactive tripeptides have an antihypertensive effect in double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes. Journal of Nutrition and Metabolism, Vol. 2010, Article ID 287030, 6 pages.
• [8] Smith, T.M., Kolars, J.C., Savaiano, D.A., Levitt, M.D., 1985. Absorption of calcium from milk and yogurt. American Journal of Clinical Nutrition 42: 1197-1200.
• [9] Jorde, R., Bønaa, K.H., 2000.Calcium from dairy products, vitamin D intake, and blood pressure: the Tromsø study. American Journal of Clinical Nutrition 71: 1530–1535.
• [10] Green, J.H., Richards, J.K., Bunning, R.L.W., 2000. Blood pressure responses to high-calcium skim milk and potassium-enriched high-calcium skim milk. Journal of Hypertension 18: 1331–1339.
• [11] Wang, H., Fox, C.S., Troy, L.M., Mckeown, N.M., Jacques, P.F., 2015. Longitudinal association of dairy consumption with the changes in blood pressure and the risk of incident hypertension: the Framingham Heart Study. British Journal of Nutrition 114: 1887–1899.
• [12] Hilpert, K.F., West, S.G., Bagshaw, D.M., Fishell, V., Barnhart, L., Lefevre, M., Most, M.M., Zemel, M.B., Chow, M., Hinderliter, A.L., Kris-Etherton, P.M., 2009. Effects of dairy products on intracellular calcium and blood pressure in adults with essential hypertension. Journal of the American Collage of Nutrition 28: 142-149.
• [13] Savijoki, K., Ingmer, H., Varmanen, P., 2006. Proteolytic systems of lactic acid bacteria. Applied Microbiology and Biotechnology 71: 394–406.
• [14] Pritchard, G.G., Coolbear, T., 1993. The physiology and biochemistry of the proteolytic system in lactic acid bacteria. FEMS Microbiology Reviews 12: 179–206.
• [15] Pihlanto, A., 2013. Lactic fermentation and bioactive peptides. In: Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes (Ed. M. Kongo), pp 282-309. www.intechopen.com.
• [16] Daien, V., Duny, Y., Ribstein, J., Du Cailar, G., Mimran, A., Villain, M., Daures, J.P., Fesler, P., 2012. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: A systematic review and meta-analysis. American Journal of Hypertensions 25: 126–132.
• [17] Yamamoto, N., Akino, A., Takano, T., 1994. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Bioscience, Biotechnology and Biochemistry 58: 776-778.
• [18] Muguerza, B., Ramos, M., Sánchez, E., Manso, M.A., Miguel, M., Aleixandre, A., Delgado, M.A., Recio, I., 2006. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. International Dairy Journal 16: 61–69.
• [19] Donkor, O.N., Henriksson, A., Vasiljevic, T., Shah, N.P., 2007. Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 86: 21-38.
• [20] Nielsen, M.S., Martinussen, T., Flambard, B., Sǿrensen, K.I., Otte, J., 2009. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: Effect of bacterial strain, fermentation pH, and storage time. International Dairy Journal 19: 155–165.
• [21] Pihlanto, A., Virtanen, T., Korhonen, H., 2010. Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. International Dairy Journal 20: 3–10.
• [22] Gonzalez-Gonzalez, C.R., Tuohy, K.M., Jauregi, P., 2011. Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: Effects of calcium, pH and peptides on the ACE-inhibitory activity. International Dairy Journal 21: 615-622.
• [23] Ahtesh, F.B., Stojanovska, L., Mathai, M.L., Apostolopoulos, V. Mishra, V.K., 2016. Proteolytic and angiotensin-converting enzyme-inhibitory activities of selected probiotic bacteria. International Journal of Food Science & Technology 51: 865–874.
• [24] Rasika, D.M.D., Ueda, T., Jayakody, L.N., Suriyagoda, L.D.B., Silva, K.F.S.T., Ando, S., Vidanarachchi, J.K., 2015. ACE-inhibitory activity of milk fermented with Saccharomyces cerevisiae K7 and Lactococcus lactis subsp. lactis NBRC 12007. Journal of the National Science Foundation Sri Lanka 43: 141-151.
• [25] Chen, Y., Li, C., Xue, J., Kwok L-Y., Yang, J., Zhang, H., Menghe, B., 2015. Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus. Journal of Dairy Science 98: 5113–5124.
• [26] Sultan, S., Huma, N., Butt, M.S., Shahid, M., 2016. Antihypertensive and antioxidant potential of water soluble peptide fraction from different yoghurts. Journal of Food Processing and Preservation DOI: 10.1111/jfpp.12979.
• [27] Leclerc, P-L., Gauthier, S.F., Bachelard, H., Santure, M., Roy, D., 2002. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. International Dairy Journal 12: 995–1004.
• [28] Otte, J., Lenhard, L., Flambard, B., Sørensen, K.I., 2011. Influence of fermentation temperature and autolysis on ACE-inhibitory activity and peptide profiles of milk fermented by selected strains of Lactobacillus helveticus and Lactococcus lactis. International Dairy Journal 21: 229-238.
• [29] Li, Y. Sadiq, F.A., Liu, T.J., JiCheng Chen, J-C., He, G-Q., 2015. Purification and identification of novel peptides with inhibitory effect against angiotensin I-converting enzyme and optimization of process conditions in milk fermented with the yeast Kluyveromyces marxianus. Journal of Functional Foods 16: 278-288.
• [30] Nakamura Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., Takano, T., 1995. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 78: 777-783.
• [31] Nakamura Y., Yamamoto, N., Sakai, K., Takano, T., 1995. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of Dairy Science 78: 1253-1257.
• [32] Yamamoto, N., Maeno, M., Takano, T., 1999. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticusCPN4. Journal of Dairy Science 82: 1388–1393.
• [33] Ashar, M.N., Chand, R., 2004. Antihypertensive peptides purified from milks fermented with Lactobacillus delbrueckiissp. bulgaricus. Milchwissenschaft 59: 14–17.
• [34] Quirós, A., Ramos, M., Muguerza, B., Delgado, M.A., Miguel, M., Aleixandre, A., Recio, I., 2007. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 17: 33–41.
• [35] Shuangquan, Tsuda, H., Miyamoto, T., 2008. Angiotensin I-converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus130B4 from camel milk in Inner Mongolia, China. Journal of the Science of Food and Agriculture 88: 2688–2692.
• [36] Chen, Y., Wang, Z., Chen, X. Liu, Y., Zhang, H., Sun, T., 2010. Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare’s milk. Journal of Dairy Science 93: 884–892.
• [37] Gonzalez-Gonzalez, C., Gibson,T., Jauregi, P., 2013. Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5. International Journal of Food Microbiology 167 131–137.
• [38] Rodríguez-Figueroa, J.C., González-Córdova, A.F., Astiazaran-Garcáa, H., Vallejo-Cordoba, B., 2013. Hypotensive and heart rate-lowering effects in rats receiving milk fermented by specific Lactococcus lactis strains. British Journal of Nutrition 109: 827–833.
• [39] Ha, G.E., Chang, O.K., Jo, S.M., Han, G.S., Park B.Y., Ham, J.S., Jeong, S.G., 2015. Identification of antihypertensive peptides derived from low molecular weight casein hydrolysates generated during fermentation by Bifidobacterium longum KACC 91563. Korean Journal of Food Science and Animal resources 35: 738-747.
• [40] Li, H., Qiu, T., Huang, G., Cao, Y., 2010. Production of gamma-aminobutyric acid by Lactobacillus brevisNCL912 using fed-batch fermentation. Microbial Cell Factories 985.
• [41] Komatsuzaki, N., Shima, J., Kawamoto, S., Momose, H., Kimura, T., 2005. Production of gamma-aminobutyric acid (GABA) by Lactobacillus paracasei isolated from traditional fermented foods. Food Microbiology 22: 497-504.
• [42] Hayakawa, K., Kimura, M., Kamata, K., 2002. Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. European Journal of Pharmacology 438: 107–113.
• [43] Hayakawa, K., Kimura, M., Kasaha, K., Matsumoto, K., Sansawa, H., Yamori, Y., 2004. Effect of a γ-aminobutyric acid-enriched dairy product on the bloodpressure of spontaneously hypertensive and normotensive Wistar–Kyotorats. British Journal of Nutrition 92: 411–417.
• [44] Inoue, K., Shirai, T., Ochiai, H., Kasao, M., Hayakawa, K., Kimura, M., Sansawa, H., 2003. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. European Journal of Clinical Nutrition 57: 490–495.
• [45] Hagi, T., Kabayashi, M., Nomura, M., 2016. Metabolome analysis of milk fermented by γ-aminobutyric acid-producing Lactococcuslactis. Journal of Dairy Science 99: 994-1001.
• [46] Fuglsang, A., Nilsson, D., Nyborg, N.C.B., 2002. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Applied and Environmental Microbiology 68: 3566–3569.
• [47] Miguel, M., Muguerza, B., Sánchez, E., Delgado, M.A., Recio, I., Ramos, M., Aleixandre, M.A., 2005. Changes in arterial blood pressure in hypertensive rats caused by long-term intake of milk fermented by Enterococcus faecalis CECT 5728. British Journal of Nutrition 94: 36–43.
• [48] Miguel, M., Gómez-Ruiz, J.A., Recio, I., Aleixandre, A., 2010. Changes in arterial blood pressure after single oral administration of milk-casein-derived peptides in spontaneously hypertensive rats. Molecular Nutrition and Food Research 54: 1422–1427.
• [49] Ramchandran, L., Shah, N.P., 2011. Yogurt can beneficially affect blood contributors of cardiovascular health status in hypertensive rats. Journal of Food Science 76: H131-H 136.
• [50] Ehlers, P.I., Kivimäki, A.S., Turpeinen, A.M., Korpela, R., Vapaatalo, H., 2011. High blood pressure-lowering and vasoprotective effects of milk products in experimental hypertension. British Journal of Nutrition 106: 1353–1363.
• [51] Rodríguez-Figueroa, J.C., González-Córdova, A.F., Torres-Llanez, M.J., Garcia, H.S., Vallejo-Cordoba, B., 2012. Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains. Journal of Dairy Science 95: 5536–5543.
• [52] Hata Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y., Takano, T., 1996. A placebo -controlled study of the effect of sour milk on blood pressure in hypertensive subjects. The American Journal of Clinical Nutrition 64: 767−771.
• [53] Seppo, L, Jauhiainen, T,Poussa, T andKorpela, R., 2003. A fermented milk high in bioactive peptides has a blood pressure–lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 773: 26–30.
• [54] Jauhiainen, T., Vapaatalo, H., Poussa, T., Kyrónpalo, S., Rasmussen, M., Korpela, R., 2005. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. American Journal of Hypertension 18: 1600-1605.
• [55] Boelsma, E., Kloek, J., 2009. Lactotripeptides and antihypertensive effects: a critical review. British Journal of Nutrition 101: 776–786.
• [56] Usinger, L., Jensen, L.T., Flambard, B., Linneberg, A., Ibsen, H., 2010. The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. Journal of Human Hypertension 24: 678–683.
• [57] Usinger, L., Ibsen, H., Linneberg, A., Azizi, M., Flambard, B., Jensen, L.T., 2010. Human in vivo study of the renin–angiotensin–aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Clinical, Physiological and Functional Imaging 30: 162–168.
• [58] Cicero, A.F.G., Gerocarni, B., Laghi, L., Borghi, C., 2011. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. Journal of Human Hypertension 25: 425–436.
• [59] Cicero,A.F.G., Aubin, F.,Azais-Braesco, V. Borghi, C., 2013. Do the lactotripeptides isoleucine–proline–proline and valine–proline–proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. American Journal of Hypertension 26: 442-450.
• [60] Dong, J-Y., Szeto, I.M.Y., Makinen, K., Gao, Q., Wang, J., Qin, L-Q., Zhao, Y., 2013. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. British Journal of Nutrition 110: 1188–1194.
• [61] Fekete, Á.A., Givens, D.I., Lovegrove, J.A., 2015. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients 7: 659-681.
• [62] Chanson-Rolle A., Aubin, F., Braesco, V., Hamasaki, T., Kitakaze, M., 2015. Influence of the lactotripeptides isoleucine-proline-proline and valine-proline-proline on systolic blood pressure in Japanese subjects: A systematic review and meta-analysis of randomized controlled trials. PlosOne http://dx.doi.org/10.1371/journal.pone.0142235.